Average Co-Inventor Count = 5.07
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (17 from 3,681 patents)
2. Bristol Meyers Squibb Company (1 from 41 patents)
3. Shanghai Fudan-zhangjiang Bio-pharmaceutical Co., Ltd. (1 from 4 patents)
4. Jn Therapeutics (1 from 1 patent)
20 patents:
1. 12024511 - Substituted imidazo[1,2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
2. 10730875 - Substituted imidazo[1,2-A]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
3. 8962660 - Oxabicyclo [2.2.2] acid GPR120 modulators
4. 8614332 - Substituted pyrazolylamides useful as glucokinase activators
5. 8222285 - 1,3-dihydroxy substituted phenylamide glucokinase activators
6. 8153677 - Substituted pyrazolylamide compounds useful as glucokinase activators
7. 7951793 - Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
8. 7910747 - Phosphonate and phosphinate pyrazolylamide glucokinase activators
9. 7888504 - Glucokinase activators and methods of using same
10. 7579479 - Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
11. 7507757 - Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
12. 7279485 - Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
13. 7241780 - Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
14. 7084162 - Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
15. 7053106 - Substituted acid derivatives useful as antidiabetic and antiobesity agents and method